Search research articles
Contact Us
Filters
Showing results (231-240 of 282) with videos related to
Page
of 29
Sort By:
British Journal of Cancer
|
May 14, 1998
Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost
S M Lee, J A Radford, L Dobson, et al.
British Medical Journal
|
July 4, 1970
Combination chemotherapy in generalized Hodgkin's disease
W M Nicholson, M E Beard, D Crowther, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera
S E Owens, N Thatcher, H Sharma, et al.
Lancet (London, England)
|
March 17, 1984
Steroid-hormone receptors and survival after first relapse in breast cancer
A Howell, D M Barnes, R N Harland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
M Van Glabbeke, A T van Oosterom, J W Oosterhuis, et al.
British Journal of Cancer
|
December 23, 1998
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
O S Nielsen, P Dombernowsky, H Mouridsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting
T A Lister, D Crowther, S B Sutcliffe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma Group
P Kerbrat, R Somers, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials
R H Begent, K A Chester, T Connors, et al.
Cancer Research
|
March 1, 1994
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families
J M Birch, A L Hartley, K J Tricker, et al.
Page
of 29
Search research articles
Search
Showing results (231-240 of 282) with videos related to
Sort By:
Page
of 29
British Journal of Cancer
|
May 14, 1998
Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost
S M Lee, J A Radford, L Dobson, et al.
British Medical Journal
|
July 4, 1970
Combination chemotherapy in generalized Hodgkin's disease
W M Nicholson, M E Beard, D Crowther, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera
S E Owens, N Thatcher, H Sharma, et al.
Lancet (London, England)
|
March 17, 1984
Steroid-hormone receptors and survival after first relapse in breast cancer
A Howell, D M Barnes, R N Harland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
M Van Glabbeke, A T van Oosterom, J W Oosterhuis, et al.
British Journal of Cancer
|
December 23, 1998
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
O S Nielsen, P Dombernowsky, H Mouridsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting
T A Lister, D Crowther, S B Sutcliffe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma Group
P Kerbrat, R Somers, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials
R H Begent, K A Chester, T Connors, et al.
Cancer Research
|
March 1, 1994
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families
J M Birch, A L Hartley, K J Tricker, et al.
Page
of 29